logo

For the Inventor, By the Inventor

County Cork, Ireland

Janssen Sciences Ireland Unlimited Company


USPTO Granted Patents = 61


Trademarks = 5

Forward Citations = 46

Loading Chart...
Loading Chart...

146 inventors (with patents filed for the assignee):

goldMedal Pierre Jean-Marie Bernard Raboisson (25 out of 178 patents)

silverMedal Tim Hugo Maria Jonckers (14 out of 77 patents)

bronzeMedal David Craig McGowan (13 out of 61 patents)

4.  Jérôme Émile Georges Guillemont (9 out of 19 patents)

5.  Anil Koul (8 out of 31 patents)

6.  David Francis Alain Lançois (7 out of 29 patents)

7.  Lieven Elvire Colette Baert (6 out of 17 patents)

8.  Dirk André Emmy Roymans (6 out of 11 patents)

9.  Stefaan Julien Last (6 out of 37 patents)

10.  Daniel Boden (5 out of 5 patents)

11.  Abdellah Tahri (5 out of 61 patents)

12.  Werner Embrechts (5 out of 18 patents)

13.  Antoine Benjamin Michaut (5 out of 7 patents)

14.  Eric Pierre Alexandre Arnoult (5 out of 13 patents)

15.  Guenter Kraus (4 out of 6 patents)


Core Competencies:
HIV Treatment
Viral Infections
Hepatitis B Virus Vaccines
Glucagon Like Peptide 1
Antibacterial Compounds
Capsid Assembly Inhibitors
Pyrimidine Derivatives
Macrocyclic Compounds
Degradable Implants
Combination Therapies
Respiratory Syncytial Virus
Amide Derivatives

61 patents:

1. 12275770 - Glucagon like peptide 1 (GLP1)-growth differentiation factor 15 (GDF15) fusion proteins and uses thereof (2025-04-14),
2. 12178815 - Regimens for treating HIV infections and aids (2024-12-31),
3. 12145933 - Hemi (L)-tartrate forms of 3-({5-chloro-1-[3-(methylsulfonyl)propyl]-1-indol-2-yl}methyl)-1-(2,2,2-trifluoroethy)-1,3-dihydro-2-imidazo[4,5-C]pyridin-2-one and pharmaceutical compositions comprising the same (2024-11-19),
4. RE50189 - Long term treatment of HIV-infection with TMC278 (2024-10-29),
5. 11918575 - PZA and cytochrome Bc1 inhibitor combination treatment (2024-03-05),
6. 11866419 - Antibacterial compounds (2024-01-09),
7. 11780900 - Glucagon like peptide 1 (GLP-1) fusion peptide coupled cyclic peptide tyrosine tyrosine conjugates and uses thereof (2023-10-10),
8. 11725194 - Hepatitis B virus (HBV) vaccines and uses thereof (2023-08-15),
9. 11713345 - Glucagon like peptide 1 (GLP1)-growth differentiation factor 15 (GDF15) fusion proteins and uses thereof (2023-08-01),
10. 11708369 - Heteroaromatic compounds having activity against RSV (2023-07-25),
11. 11702426 - Macrocyclic deaza-purinones for the treatment of viral infections (2023-07-18),
12. 11597704 - 2,4-diaminoquinazoline derivatives and medical uses thereof (2023-03-07),
13. 11564921 - Regimens for treating HIV infections and AIDS (2023-01-31),
14. 11491157 - Cycloalkyl substituted pyrazolopyrimidines having activity against RSV (2022-11-08),
15. 11491148 - Amide derivatives useful in the treatment of HBV infection or HBV-induced diseases (2022-11-08),
Janssen Sciences Ireland Unlimited Company is a subsidiary of the global pharmaceutical company Johnson & Johnson. They focus on discovering, developing, and manufacturing innovative medicines and healthcare products. With a commitment to advancing human health worldwide, Janssen Sciences Ireland contributes to the treatment of various medical conditions through their cutting-edge scientific research and collaborations with healthcare professionals.
This text is generated by artificial intelligence and may not be accurate.

logo

Company Badge

USPTO Data Jan 1 1976 - Dec 30 2025

...
61 Patents

#2 in County Cork

#54 in Ireland

#11,622 in the World

...
County Cork, Ireland

Janssen Sciences Ireland Unlimited Company

Forward Citations = 46

146 inventors:

goldMedal Pierre Jean-Marie Bernard Raboisson (25 out of 178 patents)

silverMedal Tim Hugo Maria Jonckers (14 out of 77 patents)

bronzeMedal David Craig McGowan (13 out of 61 patents)

4.  Jérôme Émile Georges Guillemont (9 out of 19 patents)

5.  Anil Koul (8 out of 31 patents)

Please report any incorrect information to support@idiyas.com
Loading…